Xiaofei Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Xiaofei Lin has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Bo Sun
Department of Pediatrics, National Health Commission Laboratory of Neonatal Diseases, National Children’s Medical Center and Children’s Hospital of Fudan University, China
1 shared publication - Changqiang Msc Cui
Department of Pediatrics, Huai’an Maternal and Child Health Care center (The Huai’an Maternity and Child Clinical College of Xuzhou Medical University), Huaian, Jiangsu, China
1 shared publication - Haijun Wang
Department of Pediatrics, Lianshui County People’s Hospital, Affiliated Hospital of Kangda College, Nanjing Medical University, Jiangsu, China
1 shared publication - Hongli Zhu
Department of Pediatrics, Huai’an Maternal and Child Health Care Hospital, Huaian, Jiangsu, 223002, China
1 shared publication - Hongni Yue
Department of Neonatology, Huai’an Women and Children’s Hospital
1 shared publication - Li Msc Zha
Department of Pediatrics, Huai’an Maternal and Child Health Care center (The Huai’an Maternity and Child Clinical College of Xuzhou Medical University), Huaian, Jiangsu, China
1 shared publication
Latest Publications
- Open Access
- 18 July 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1606264
The effect of probiotics on the diarrhea and constipation outcomes in children: an umbrella review of systematic reviews and meta-analyses
Background: The existing literature on the effects of probiotics on diarrhea and constipation outcomes remains inconsistent. Therefore, this umbrella review of systematic reviews and meta-analyses aims to provide a concise and definite understanding in relation to the effect of probiotics on diarrhea and constipation in children.Methods: A comprehensive systematic search was carried out in on Scopus, PubMed, Embase, Web of Science, and Google Scholar up to December 2024. The overall effect size was calculated using random effect model. Also, subgroup analyses were performed regarding age group, health condition, single or multi-strain probiotics.Results: This umbrella study comprises a systematic review of 35 studies. Our findings illustrated that probiotics reduce odds [odds ratio (OR) = 0.51; 95% confidence interval (CI): 0.27, 0.94] and risk of diarrhea incidence [relative risk (RR) = 0.54; 95% CI: 0.40, 0.71] compared to control group, meaningfully. Also, it is successful in reducing diarrhea duration [weighted mean difference (WMD) = −1.85; 95% CI: −2.83, −0.86] and [standardized mean difference (SMD) = −0.94; 95% CI: −1.32, −0.56] significantly. Moreover, probiotics supplementation resulted in decreased stool frequency (WMD = −0.21; 95% CI: −0.37, −0.04). Probiotics prevent diarrhea by about 36% (RR = 0.64; 95% CI: 0.63, 0.65(, and significantly improved diarrhea treatment (SMD = −0.49; 95% CI: −0.59, −0.38). Also, the analyses revealed that probiotics significantly impact on constipation (OR = 1.17, 95% CI: 1.01–1.37).Conclusion: This meta-analysis supports the potential role of probiotics in relation to diarrhea and constipation outcome in children. Probiotic supplementation contributed to a declined risk and odds of diarrhea incidence. Also, probiotic supplementation was accompanied with decreased diarrhea duration.
- 18 July 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1606264
Open AccessThe effect of probiotics on the diarrhea and constipation outcomes in children: an umbrella review of systematic reviews and meta-analyses
Background: The existing literature on the effects of probiotics on diarrhea and constipation outcomes remains inconsistent. Therefore, this umbrella review of systematic reviews and meta-analyses aims to provide a concise and definite understanding in relation to the effect of probiotics on diarrhea and constipation in children.Methods: A comprehensive systematic search was carried out in on Scopus, PubMed, Embase, Web of Science, and Google Scholar up to December 2024. The overall effect size was calculated using random effect model. Also, subgroup analyses were performed regarding age group, health condition, single or multi-strain probiotics.Results: This umbrella study comprises a systematic review of 35 studies. Our findings illustrated that probiotics reduce odds [odds ratio (OR) = 0.51; 95% confidence interval (CI): 0.27, 0.94] and risk of diarrhea incidence [relative risk (RR) = 0.54; 95% CI: 0.40, 0.71] compared to control group, meaningfully. Also, it is successful in reducing diarrhea duration [weighted mean difference (WMD) = −1.85; 95% CI: −2.83, −0.86] and [standardized mean difference (SMD) = −0.94; 95% CI: −1.32, −0.56] significantly. Moreover, probiotics supplementation resulted in decreased stool frequency (WMD = −0.21; 95% CI: −0.37, −0.04). Probiotics prevent diarrhea by about 36% (RR = 0.64; 95% CI: 0.63, 0.65(, and significantly improved diarrhea treatment (SMD = −0.49; 95% CI: −0.59, −0.38). Also, the analyses revealed that probiotics significantly impact on constipation (OR = 1.17, 95% CI: 1.01–1.37).Conclusion: This meta-analysis supports the potential role of probiotics in relation to diarrhea and constipation outcome in children. Probiotic supplementation contributed to a declined risk and odds of diarrhea incidence. Also, probiotic supplementation was accompanied with decreased diarrhea duration.
- RetractedOpen Access
- 9 August 2022
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-8
Evaluation Value and Clinical Significance of Cardiac Troponin Level and Pediatric Sequential Organ Failure Score in the Definition of Sepsis 3.0 in Critically Ill Children
Objective. A case-control study was conducted to explore the value and clinical significance of troponin level and pediatric sequential organ failure score in the evaluation of sepsis 3.0 definition in critically ill children. Methods. 180 children with sepsis who were admitted to the ICU from March 2019 to June 2021 were enrolled in our hospital as the research objects. In addition, 100 children with general infection did not meet the diagnostic criteria of systemic inflammatory response syndrome (SIRS) as controls. The creatine kinase MB (CK-MB) and cardiac troponin I (cTnI) data at the 1st and 24-72 h after admission to pediatric intensive care unit (PICU) were enrolled as the observation indexes of myocardial enzymology. In the meantime, the relevant literature was reviewed to obtain the indicators related to sepsis death. The data of the first examination in the medical history data were enrolled for analysis. According to the definition of sepsis 3.0 in critically ill children, they were assigned into sepsis and nonsepsis group. According to the survival outcome of discharge and 30 days after discharge, the patients were assigned into the death subgroup and survival subgroup and were assigned into the sequential organ failure assessment (SOFA) score >= 2 subgroup and < 2 subgroup according to SOFA score. COX proportional hazard regression was used to analyze the relationship between CK-MB, cTnI, and SOFA scores and prognosis. ROC curve was adopted to analyze the value of CK-MB, cTnI, and SOFA scores in the evaluation of critical sepsis in children. Results. Univariate analysis indicated that the prognosis of children with sepsis was correlated with abnormal levels of CK-MB and cTnI, SOFA score, oxygenation index < 200, mean arterial pressure, and Glasgow coma scale (GCS), and the difference was statistically significant (P < 0.05). The results of COX regression analysis indicated that the variables that were remarkably associated with death from sepsis in children were CK-MB, elevated cTnI levels, and SOFA score >= 2, and serum cTnI and/or CK-MB levels and SOFA score were remarkably higher correlation (r = 0.453, P < 0.05). In terms of the myocardial enzyme levels in the sepsis group and the nonsepsis group, the levels of CK-MB and (or) cTnI augmented in 121/180 cases (67.22%) in the sepsis group and in 19/100 cases (19.00%) in the nonsepsis group. The levels of CK-MB and (or) cTnI were augmented, and the difference was statistically significant (P < 0.05). The levels of CK-MB and cTnI in the sepsis group at admission to ICU and 24 to 72 hours after admission were remarkably higher compared to the nonsepsis group. The levels of CK-MB and cTnI at 24-72 h were higher compared to ICU. The myocardial enzyme levels of different SOFA scores and survival outcome subgroups in the sepsis group were compared. The subgroup with SFOA score >= 2 points had remarkably higher levels of CK-MB and (or) cTnI than the subgroup with < 2 points. The survival subgroup of CK-MB and cTnI level was remarkably higher compared to the death subgroup, the CK-MB and cTnI levels in each subgroup at 224-72 hours were remarkably higher compared to the ICU, and the difference was statistically significant (P < 0.05). Kaplan-Meier method and log-rank test indicated that the survival rates of groups 1 to 4 at 30 days were 33.23%, 78.71%, 40.03%, and 100.00%, respectively. The average survival time and their 95% CI were 12.82 d (10.52 similar to 16.26 d), 22.34 d (18.76 similar to 25.81 d), 14.65 d (11.62 similar to 16.38 d), and 30 d (30.00 similar to 30.00 d), respectively. Pairwise comparison indicated that the survival time of children in group 1 was the shortest, and that in group 4 was the longest. The results of ROC curve research showed that the CK-MB, cTnI, and SOFA scores and AUC for the combination test were 0.778 (95% CI 0.642-0.914), 0.736 (95% CI 0.602-0.890), 0.848 (95% CI 0.733-0.963), and 0.934 (95% CI 0.854-0.999), respectively. The AUC of combined diagnosis was remarkably higher compared to single factor prediction, and the difference was statistically significant (P < 0.05). Predictive value showed the joint test > SOFA score > CK - MB > cTnI. Conclusion. Troponin level and pediatric SOFA score can be adopted as effective indicators to assess the severity and prognosis of patients with sepsis and can guide the formulation of a reasonable treatment plan.
- 9 August 2022
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-8
RetractedOpen AccessEvaluation Value and Clinical Significance of Cardiac Troponin Level and Pediatric Sequential Organ Failure Score in the Definition of Sepsis 3.0 in Critically Ill Children
Objective. A case-control study was conducted to explore the value and clinical significance of troponin level and pediatric sequential organ failure score in the evaluation of sepsis 3.0 definition in critically ill children. Methods. 180 children with sepsis who were admitted to the ICU from March 2019 to June 2021 were enrolled in our hospital as the research objects. In addition, 100 children with general infection did not meet the diagnostic criteria of systemic inflammatory response syndrome (SIRS) as controls. The creatine kinase MB (CK-MB) and cardiac troponin I (cTnI) data at the 1st and 24-72 h after admission to pediatric intensive care unit (PICU) were enrolled as the observation indexes of myocardial enzymology. In the meantime, the relevant literature was reviewed to obtain the indicators related to sepsis death. The data of the first examination in the medical history data were enrolled for analysis. According to the definition of sepsis 3.0 in critically ill children, they were assigned into sepsis and nonsepsis group. According to the survival outcome of discharge and 30 days after discharge, the patients were assigned into the death subgroup and survival subgroup and were assigned into the sequential organ failure assessment (SOFA) score >= 2 subgroup and < 2 subgroup according to SOFA score. COX proportional hazard regression was used to analyze the relationship between CK-MB, cTnI, and SOFA scores and prognosis. ROC curve was adopted to analyze the value of CK-MB, cTnI, and SOFA scores in the evaluation of critical sepsis in children. Results. Univariate analysis indicated that the prognosis of children with sepsis was correlated with abnormal levels of CK-MB and cTnI, SOFA score, oxygenation index < 200, mean arterial pressure, and Glasgow coma scale (GCS), and the difference was statistically significant (P < 0.05). The results of COX regression analysis indicated that the variables that were remarkably associated with death from sepsis in children were CK-MB, elevated cTnI levels, and SOFA score >= 2, and serum cTnI and/or CK-MB levels and SOFA score were remarkably higher correlation (r = 0.453, P < 0.05). In terms of the myocardial enzyme levels in the sepsis group and the nonsepsis group, the levels of CK-MB and (or) cTnI augmented in 121/180 cases (67.22%) in the sepsis group and in 19/100 cases (19.00%) in the nonsepsis group. The levels of CK-MB and (or) cTnI were augmented, and the difference was statistically significant (P < 0.05). The levels of CK-MB and cTnI in the sepsis group at admission to ICU and 24 to 72 hours after admission were remarkably higher compared to the nonsepsis group. The levels of CK-MB and cTnI at 24-72 h were higher compared to ICU. The myocardial enzyme levels of different SOFA scores and survival outcome subgroups in the sepsis group were compared. The subgroup with SFOA score >= 2 points had remarkably higher levels of CK-MB and (or) cTnI than the subgroup with < 2 points. The survival subgroup of CK-MB and cTnI level was remarkably higher compared to the death subgroup, the CK-MB and cTnI levels in each subgroup at 224-72 hours were remarkably higher compared to the ICU, and the difference was statistically significant (P < 0.05). Kaplan-Meier method and log-rank test indicated that the survival rates of groups 1 to 4 at 30 days were 33.23%, 78.71%, 40.03%, and 100.00%, respectively. The average survival time and their 95% CI were 12.82 d (10.52 similar to 16.26 d), 22.34 d (18.76 similar to 25.81 d), 14.65 d (11.62 similar to 16.38 d), and 30 d (30.00 similar to 30.00 d), respectively. Pairwise comparison indicated that the survival time of children in group 1 was the shortest, and that in group 4 was the longest. The results of ROC curve research showed that the CK-MB, cTnI, and SOFA scores and AUC for the combination test were 0.778 (95% CI 0.642-0.914), 0.736 (95% CI 0.602-0.890), 0.848 (95% CI 0.733-0.963), and 0.934 (95% CI 0.854-0.999), respectively. The AUC of combined diagnosis was remarkably higher compared to single factor prediction, and the difference was statistically significant (P < 0.05). Predictive value showed the joint test > SOFA score > CK - MB > cTnI. Conclusion. Troponin level and pediatric SOFA score can be adopted as effective indicators to assess the severity and prognosis of patients with sepsis and can guide the formulation of a reasonable treatment plan.
- Open Access
- 8 January 2019
- Published by Springer Nature in BMC Pediatrics
- Vol. 19 (1) , 11
Evaluation of systemic inflammatory response syndrome-negative sepsis from a Chinese regional pediatric network
The identification of sepsis in children varies depending on the definition used. Our purpose was to compare clinical data and outcome of atypical sepsis, manifested as having sepsis but not fulfilling the criteria of systemic inflammatory response syndrome (SIRS-negative sepsis, SNS), in children based on the modified Angus criteria with those of sepsis (S) and severe sepsis (SS) based on the international consensus criteria. Pediatric departments in 11 regional city and county referral hospitals with emergency and intensive care settings in Huai’an serving for 843,000 children participated in a parallel multicenter prospective survey. Clinical data registry was used to recruit those who fulfilled the diagnostic criteria for pediatric sepsis from all admissions (n = 27,836) from 28 days to 15 years old, from September 1, 2010 to August 31, 2011. A total of 1606 children met the criteria for pediatric sepsis and were divided into three groups: S, (n = 1377), SS (n = 153, including 32 septic shock), based on the consensus definition criteria, and SNS (n = 76) based on the modified Angus criteria. Most deaths (38/54, 70.3%) occurred within three days of admission. The SNS mainly occurred in infants and was associated with cardiopulmonary and neurologic dysfunction without satisfying the SIRS criteria. SNS differed from SS in that it predominantly affected infants and manifested with cardiopulmonary and neurologic dysfunction. There were no laboratory variables which were useful in identification of SNS, or predicting response to therapy or outcome.
- 8 January 2019
- Published by Springer Nature in BMC Pediatrics
- Vol. 19 (1) , 11
Open AccessEvaluation of systemic inflammatory response syndrome-negative sepsis from a Chinese regional pediatric network
The identification of sepsis in children varies depending on the definition used. Our purpose was to compare clinical data and outcome of atypical sepsis, manifested as having sepsis but not fulfilling the criteria of systemic inflammatory response syndrome (SIRS-negative sepsis, SNS), in children based on the modified Angus criteria with those of sepsis (S) and severe sepsis (SS) based on the international consensus criteria. Pediatric departments in 11 regional city and county referral hospitals with emergency and intensive care settings in Huai’an serving for 843,000 children participated in a parallel multicenter prospective survey. Clinical data registry was used to recruit those who fulfilled the diagnostic criteria for pediatric sepsis from all admissions (n = 27,836) from 28 days to 15 years old, from September 1, 2010 to August 31, 2011. A total of 1606 children met the criteria for pediatric sepsis and were divided into three groups: S, (n = 1377), SS (n = 153, including 32 septic shock), based on the consensus definition criteria, and SNS (n = 76) based on the modified Angus criteria. Most deaths (38/54, 70.3%) occurred within three days of admission. The SNS mainly occurred in infants and was associated with cardiopulmonary and neurologic dysfunction without satisfying the SIRS criteria. SNS differed from SS in that it predominantly affected infants and manifested with cardiopulmonary and neurologic dysfunction. There were no laboratory variables which were useful in identification of SNS, or predicting response to therapy or outcome.